Published in Can J Vet Res on April 01, 1999
Distribution of a specific 500-base-pair fragment in mycobacterium bovis isolates from Sardinian cattle. J Clin Microbiol (2000) 0.95
Evaluation of pathogenesis caused in cattle and guinea pig by a Mycobacterium bovis strain isolated from wild boar. BMC Vet Res (2011) 0.84
Detection of Mycobacterium bovis DNA in nasal swabs from tuberculous cattle by a multiplex PCR. Braz J Microbiol (2010) 0.82
Molecular findings and approaches spotlighting Mycobacterium bovis persistence in cattle. Vet Res (2009) 0.81
Molecular detection of Mycobacterium bovis in cattle herds of the state of Pernambuco, Brazil. BMC Vet Res (2016) 0.75
Occurrence and Distribution of bovine tuberculosis (Mycobacterium bovis) in Slaughtered cattle in the abattoirs of Bauchi State, Nigeria. Vet World (2015) 0.75
Detection of Mycobacterium bovis in Organs of Slaughtered Cattle by DNA-Based Polymerase Chain Reaction and Ziehl-Neelsen Techniques in Bauchi State, Nigeria. J Vet Med (2015) 0.75
Identification of mycobacteria from culture by using the Gen-Probe Rapid Diagnostic System for Mycobacterium avium complex and Mycobacterium tuberculosis complex. J Clin Microbiol (1988) 7.74
Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol (1991) 5.99
Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA (1995) 5.94
The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis (1995) 5.20
The bovine tubercle bacillus. J Appl Bacteriol (1983) 2.72
The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis (1997) 2.64
MPB70, a unique antigen of Mycobacterium bovis BCG. Am Rev Respir Dis (1984) 2.45
Genomic analysis of Mycobacterium bovis and other members of the Mycobacterium tuberculosis complex by isoenzyme analysis and pulsed-field gel electrophoresis. J Clin Microbiol (1996) 2.08
Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect Immun (1997) 2.05
A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle. Aust Vet J (1990) 2.04
Field comparison of the interferon-gamma assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis. Aust Vet J (1991) 1.82
Species-specific identification of Mycobacterium bovis by PCR. Microbiology (1995) 1.68
Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence. Infect Immun (1991) 1.63
Simple procedure of DNA isolation from human serum. Nucleic Acids Res (1991) 1.44
The sensitivity and specificity of various tuberculin tests using bovine PPD and other tuberculins. Vet Rec (1978) 1.37
Purification of a major Mycobacterium bovis antigen for the diagnosis of bovine tuberculosis. Scand J Immunol (1989) 1.32
Production of reference PPD tuberculins for veterinary use in the United States. J Biol Stand (1978) 0.93
Detection of Mycobacterium bovis in bovine blood by combined PCR and DNA probe methods. Vet Rec (1993) 0.83
Diagnosis of cutaneous tuberculosis by polymerase chain reaction using a species-specific gene. Int J Dermatol (1996) 0.80
Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol (1991) 5.99
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect Immun (1986) 3.80
Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med (1984) 3.49
Human antibodies to a Mr 155,000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion. Proc Natl Acad Sci U S A (1984) 2.52
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. J Immunol (1987) 2.27
A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature (1988) 2.26
MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG. Int Arch Allergy Appl Immunol (1986) 2.25
Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (1987) 1.85
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med (1979) 1.79
Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet (1993) 1.79
Multiprimer PCR system for differential identification of mycobacteria in clinical samples. J Clin Microbiol (1996) 1.68
Species-specific identification of Mycobacterium bovis by PCR. Microbiology (1995) 1.68
Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence. Infect Immun (1991) 1.63
Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol (1983) 1.53
An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med (1985) 1.52
Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. Proc Natl Acad Sci U S A (1986) 1.51
Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol (1985) 1.46
Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg (1992) 1.41
Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol Biochem Parasitol (1996) 1.39
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Regulation of the immune response in Plasmodium falciparum malaria. III. Proliferative response to antigen in vitro and subset composition of T cells from patients with acute infection or from immune donors. Clin Exp Immunol (1984) 1.32
A species-specific nucleotide sequence of Mycobacterium tuberculosis encodes a protein that exhibits hemolytic activity when expressed in Escherichia coli. Infect Immun (1995) 1.21
Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature (1979) 1.15
Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A (1995) 1.15
T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun (2001) 1.11
Regulation of the immune response in Plasmodium falciparum malaria. I. Non-specific proliferative responses in vitro and characterization of lymphocytes. Clin Exp Immunol (1983) 1.10
Amplification of a 500-base-pair fragment from cultured isolates of Mycobacterium bovis. J Clin Microbiol (1999) 1.10
Viral hepatitis in Colombia: a study of the "hepatitis of the Sierra Nevada de Santa Marta". Hepatology (1985) 1.05
Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci (2003) 1.05
Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course. Infect Immun (1991) 1.05
Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. Vaccine (2004) 1.02
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immun (1999) 1.01
Plasmodium falciparum AMA-1 erythrocyte binding peptides implicate AMA-1 as erythrocyte binding protein. Vaccine (2000) 1.00
Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunol Lett (1995) 1.00
Identification of Plasmodium falciparum MSP-1 peptides able to bind to human red blood cells. Parasite Immunol (1996) 0.98
Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotides. Parasite Immunol (1991) 0.98
Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86). Vet Immunol Immunopathol (2002) 0.98
Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization. Exp Parasitol (1999) 0.97
Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro. Clin Exp Immunol (1987) 0.96
Characterization and localization of Plasmodium falciparum surface antigens on infected erythrocytes from west African patients. Blood (1991) 0.95
Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase. Mol Biochem Parasitol (1992) 0.94
Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates. Exp Parasitol (2000) 0.93
Isolation and identification of mycobacteria in New World primates maintained in captivity. Vet Microbiol (2004) 0.93
Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis. Immunol Lett (1995) 0.91
Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine (2001) 0.91
Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis. Clin Exp Immunol (1996) 0.91
Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am J Trop Med Hyg (1990) 0.90
Functional and structural similarity of V gamma 9V delta 2 T cells in humans and Aotus monkeys, a primate infection model for Plasmodium falciparum malaria. J Immunol (2001) 0.90
Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis. Clin Exp Immunol (1999) 0.89
Geographical distribution of Plasmodium falciparum erythrocyte rosetting and frequency of rosetting antibodies in human sera. Am J Trop Med Hyg (1990) 0.89
During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins. Clin Exp Immunol (1995) 0.88
Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells. Parasitology (2000) 0.87
Plasmodium falciparum: red blood cell binding studies of peptides derived from histidine-rich KAHRP-I, HRP-II and HRP-III proteins. Acta Trop (2000) 0.87
Immunogenic synthetic peptides against mycobacteria of potential immunodiagnostic and immunoprophylactic value. Lepr Rev (1986) 0.87
Quantum chemical analysis of MHC-peptide interactions for vaccine design. Mini Rev Med Chem (2010) 0.86
Sequence and diversity of MHC DQA and DQB genes of the owl monkey Aotus nancymaae. Immunogenetics (2000) 0.84
Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine (2001) 0.84
Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera. Clin Exp Immunol (2001) 0.84
Sequence and diversity of DRB genes of Aotus nancymaae, a primate model for human malaria parasites. Immunogenetics (2000) 0.83
Specific interactions of synthetic peptides derived from P. falciparum merozoite proteins with human red blood cells. Pept Res (1992) 0.83
Mapping of antigenic determinants of the T. cruzi hsp70 in chagasic and healthy individuals. Mol Immunol (1993) 0.83
Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion. J Pept Res (2000) 0.83
Plasmodium falciparum EBA-140 kDa protein peptides that bind to human red blood cells. J Pept Res (2003) 0.83
Shifting the polarity of some critical residues in malarial peptides' binding to host cells is a key factor in breaking conserved antigens' code of silence. Med Chem (2008) 0.83
Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres. Vaccine (2002) 0.82
Mapping of the linear antigenic determinants of the Leishmania infantum hsp70 recognized by leishmaniasis sera. Immunol Lett (1996) 0.82
Activation pattern and toxicity of the Cry11Bb1 toxin of Bacillus thuringiensis subsp. medellin. J Invertebr Pathol (2000) 0.82
Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin Exp Immunol (1991) 0.81
Cultivation and characterization of stable Leishmania guyanensis complex axenic amastigotes derived from infected U937 cells. Am J Trop Med Hyg (2001) 0.81
Malaria vaccines. Curr Opin Immunol (1995) 0.81
Identification of a particular B cell alloantigen associated with susceptibility to lepromatous leprosy. Lepr Rev (1981) 0.81
Effects of hCG as spermiation inducer on European eel semen quality. Theriogenology (2006) 0.81
Immunoglobulin kappa light-chain V, J, and C gene sequences of the owl monkey Aotus nancymaae. Immunogenetics (2000) 0.80
Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region. Mol Biochem Parasitol (2001) 0.80
Diagnosis of cutaneous tuberculosis by polymerase chain reaction using a species-specific gene. Int J Dermatol (1996) 0.80
Synthesis, isolation and characterization of Plasmodium falciparum antigenic tetrabranched peptide dendrimers obtained by thiazolidine linkages. J Pept Res (2001) 0.80
Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens. Am J Trop Med Hyg (1990) 0.80
Alpha1 and alpha2 domains of Aotus MHC class I and Catarrhini MHC class Ia share similar characteristics. Tissue Antigens (2003) 0.79
Erythema nodosum leprosum. Arch Dermatol (1977) 0.79
Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia. Vaccine (1996) 0.79
Functional, immunological and three-dimensional analysis of chemically synthesised sporozoite peptides as components of a fully-effective antimalarial vaccine. Curr Med Chem (2011) 0.79
Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms. Pharmacol Res (2001) 0.79
Sequence of the cry11Bb11 gene from Bacillus thuringiensis subsp. medellin and toxicity analysis of its encoded protein. Biochim Biophys Acta (1998) 0.79
Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes. Vaccine (2000) 0.78
Plasmodium falciparum circumsporozoite (CS) protein peptides specifically bind to HepG2 cells. Vaccine (2001) 0.78
Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66. Int J Pharm (2003) 0.78
Serine repeat antigen peptides which bind specifically to red blood cells. Parasitol Int (2000) 0.78
Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein. Peptides (2007) 0.78
Synthetic peptides from Plasmodium falciparum apical membrane antigen 1 (AMA-1) specifically interacting with human hepatocytes. Biochimie (2006) 0.78
Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66. Parasite Immunol (1992) 0.78
Plasmodium falciparum: binding studies of peptide derived from the sporozoite surface protein 2 to Hep G2 cells. J Pept Res (2001) 0.77
Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years. Vaccine (1992) 0.77
In human malaria protective antibodies are directed mainly against the Lys-Glu ion pair within the Lys-Glu-Lys motif of the synthetic vaccine SPf 66. Parasite Immunol (1992) 0.77
Prevalence of infection with high-risk human papillomavirus in women in Colombia. Clin Microbiol Infect (2008) 0.77
Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages. Amino Acids (2011) 0.77